Navigation Links
Physician Group Opposes FDA's Position on Adult Stem Cells
Date:3/26/2009

The American Stem Cell Therapy Association (ASCTA) is formed in response to the Food and Drug Administration's (FDA) recent position that the adult stem cells found in everyone's body are drugs, a position the ASCTA opposes. This physician organization is establishing laboratory guidelines that will allow doctors to bring adult stem cell therapy to their patients more quickly.

Broomfield, CO (PRWEB) March 26, 2009 -- The American Stem Cell Therapy Association (ASCTA) announced today the online publication of its mission statements and charter. The organization was formed in response to the Food and Drug Administration's (FDA) recent position that the adult stem cells found in everyone's body are drugs, a position the ASCTA opposes. This physician organization is establishing laboratory guidelines that will allow doctors to bring adult stem cell therapy to their patients more quickly. These guidelines will be similar to those used by fertility specialists in In-Vitro Fertilization (IVF) labs, where many of the same cell culture techniques are used.

"Many patients are dying or suffering daily with incurable diseases or problems that require major surgery. These patients should have access to basic adult stem cell therapy now." stated Christopher J. Centeno, M.D, an ASCTA physician member. "ASCTA is establishing guidelines which will allow the safe use of the patient's own adult stem cells under the supervision of doctors." continued Centeno. Another ASCTA physician member, Frank Falco, M.D. stated, "The FDA's position against someone using their own stem cells is taking it too far. We are talking about a person using their own tissue to treat a degenerative disorder or process safely without the use of medications or surgery. Although we agree that oversight and standards are necessary, this should be provided through a physician organization such as ASCTA rather than by a government agency."

Adult stem cells are different than embryonic stem cells. Adult stem cells are found in the patient's body in various tissues. In order to obtain enough stem cells for treatment, they often need to be cultured, similar to today's fertility treatments. Adult stem cells have undergone much more research than embryonic stem cells and therefore are closer to real world treatments. These adult stem cells are taken from the patient's own body (autologous) and ACSTA believes that they are therefore the safest for use in treating patients. "While the Obama administration seems to have opened the embryonic stem cell door, their FDA seems to want to slam the adult stem cell door shut", stated Dr. Centeno.

About the American Stem Cell Therapy Association
The ASCTA is a physician group comprised of various medical and surgical specialties whose goal is to bring safe stem cell therapy to patients by establishing laboratory and clinical guidelines. Christopher J. Centeno, M.D. is a board certified pain management specialist in Colorado who utilizes The Regenexx Procedure, an innovative adult stem cell therapy that helps patients avoid the need for more invasive orthopedic surgery. Dr. Centeno has published numerous medical research papers on the clinical application of adult mesenchymal stem cells. Frank Falco, M.D. is a board certified pain management physician and program director of the Temple University Hospital pain medicine fellowship located in Philadelphia, Pennsylvania who implements minimally invasive techniques for treatment of painful conditions including degenerative spine disorders. For more information, visit http://www.stemcelldocs.org.

Press contact:
Holly Hamann
720-290-0007

###

Read the full story at http://www.prweb.com/releases/ASCTA/stemcelltherapy/prweb2264534.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. TMA Physicians and Legislators: Patients Have a Right to Know
2. AMA Announces Physician Class Action Against WellPoint
3. Physicians Practice and Rose Medical Center Partner to Improve Patient Care in the Denver Metro Area
4. Intensive summer program helps physicians build clinical research careers
5. Manhattan Research: Physician New Media Adoption in Emerging Pharma Markets - Webcast April 3
6. New book chronicles the journeys of women physicians and scientists to fighting cancer
7. Sound Inpatient Physicians Report on New Clinical Processes to Reduce Healthcare Costs and Enhance Care
8. In Texas, Favorable Regulations for Physicians May Backfire in Light of Market Downturn
9. New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer
10. Physicians Favor Patient Involvement in Decision Making, But Cite Barriers Such as Time and Money
11. U.S. Rep. Connolly, Inova Health System Physicians, Public Health Groups Call for Congressional Action to Protect Kids from Tobacco
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Physician Group Opposes FDA's Position on Adult Stem Cells
(Date:1/17/2017)... ... January 17, 2017 , ... ... century approach to infusing high speed technology into the fabric of an entire ... the advancement of healthcare and wellness in a yet-to-be-named, health focused campus. Leading ...
(Date:1/17/2017)... ... 17, 2017 , ... Surgeons from New York’s fastest growing ... on the latest breakthroughs in the prevention, diagnosis and treatment of the most ... eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD and Managing ...
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading ... a Principal in its IT Advisory Services practice . Rossi is the third ... market demand for strategic IT guidance grows, and the practice continues to expand.     , ...
(Date:1/17/2017)... York, NY (PRWEB) , ... January 17, 2017 ... ... Inc. Magazine’s fastest-growing private companies and ranked among the top US security companies ... Board of Directors. This announcement brings a year-long independent board nomination process ...
(Date:1/16/2017)... , ... January 17, 2017 , ... Recently, patients and ... Southwest Michigan, joined other volunteers and organizations in support of the annual Binder Park ... and families dressed up in colorful costumes of all designs coming out to enjoy ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan 17, 2017 Research and ... Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), ... - Global Forecast to 2021" report to their offering. ... The global active ... 2021 from USD 157.95 Billion in 2016, growing at a CAGR ...
(Date:1/17/2017)... 17, 2017 Immune Pharmaceuticals (NASDAQ: ... today that it will hold a Satellite Symposium on February ... (ISAL) XVI in Munich, Germany . ... Efficacy of Immunotherapy for the maintenance of remission in ... 20 th , 2017 from 12:45 – 13:45 CET ...
(Date:1/17/2017)... PARSIPPANY, N.J. , Jan. 17, 2017 Interpace ... that provides clinically useful molecular diagnostic tests and pathology ... it has received a letter dated January 13, 2017 ... it has regained compliance with the requirement of the ... price of $1.00 per share. The letter ...
Breaking Medicine Technology: